Gastroenterologist Robert Burakoff discusses how personalized treatment for Crohn’s disease and other chronic inflammatory diseases can improve the lives of patients. He shares how personalized treatment impacts the pharmaceutical industry and why it is the most promising approach.
Robert Burakoff MD, MPH is a Clinical Chief of the Division of Gastroenterology and Director of the Center of Digestive Health at Brigham and Women’s Hospital. He is also Professor of Medicine at Harvard Medical School. His clinical interests include Barrett’s esophagus, Crohn’s disease, gastroesophageal reflux disease (GERD), gastrointestinal disease, infectious colitis, inflammatory bowel disease, irritable bowel, and motility disorders.